Shelton Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.2M Sell
62,062
-64,093
-51% -$14.9M 0.33% 70
2025
Q4
$26.1M Sell
126,155
-25,558
-17% -$5.05M 0.52% 47
2025
Q3
$28.1M Buy
151,713
+64,326
+74% +$11M 0.6% 31
2025
Q2
$13.3M Buy
87,387
+13,626
+18% +$2.09M 0.31% 84
2025
Q1
$12.2M Buy
73,761
+13,200
+22% +$2.07M 0.29% 90
2024
Q4
$8.76M Sell
60,561
-352
-0.6% -$54.5K 0.22% 112
2024
Q3
$9.87M Sell
60,913
-18,053
-23% -$2.88M 0.25% 95
2024
Q2
$11.5M Sell
78,966
-11,423
-13% -$1.7M 0.31% 71
2024
Q1
$14.3M Sell
90,389
-17,960
-17% -$2.86M 0.41% 52
2023
Q4
$17M Buy
108,349
+13,203
+14% +$2.02M 0.54% 37
2023
Q3
$14.8M Sell
95,146
-10,900
-10% -$1.8M 0.54% 34
2023
Q2
$17.6M Buy
106,046
+4,387
+4% +$708K 0.63% 23
2023
Q1
$15.8M Buy
101,659
+62,659
+161% +$10.1M 0.66% 24
2022
Q4
$6.89M Sell
39,000
-49,000
-56% -$8.46M 0.72% 23
2022
Q3
$14.4M Buy
88,000
+20,995
+31% +$3.55M 0.68% 26
2022
Q2
$11.9M Buy
67,005
+6,456
+11% +$1.15M 0.53% 37
2022
Q1
$10.7M Buy
60,549
+15,000
+33% +$2.55M 0.4% 57
2021
Q4
$7.79M Sell
45,549
-265
-0.6% -$43.4K 0.28% 83
2021
Q3
$7.4M Sell
45,814
-100
-0.2% -$17.1K 0.29% 79
2021
Q2
$7.56M Sell
45,914
-45,432
-50% -$7.52M 0.29% 77
2021
Q1
$15M Buy
91,346
+46,845
+105% +$7.58M 0.52% 36
2020
Q4
$7M Sell
44,501
-925
-2% -$137K 0.31% 66
2020
Q3
$6.76M Sell
45,426
-2,615
-5% -$387K 0.28% 76
2020
Q2
$6.76M Buy
48,041
+16,700
+53% +$2.43M 0.37% 57
2020
Q1
$4.11M Sell
31,341
-2,189
-7% -$311K 0.3% 70
2019
Q4
$4.89M Buy
33,530
+1,650
+5% +$224K 0.27% 76
2019
Q3
$4.13M Sell
31,880
-700
-2% -$92.2K 0.24% 82
2019
Q2
$4.54M Buy
32,580
+27,844
+588% +$3.85M 0.26% 77
2019
Q1
$33.9K Sell
4,736
-30,330
-86% -$4.06M 0.13% 156
2018
Q4
$4.53M Buy
35,066
+1,035
+3% +$144K 0.31% 73
2018
Q3
$4.7M Buy
34,031
+250
+0.7% +$33.2K 0.27% 82
2018
Q2
$4.1M Sell
33,781
-1,434
-4% -$179K 0.26% 91
2018
Q1
$4.51M Sell
35,215
-1,346
-4% -$182K 0.3% 75
2017
Q4
$5.11M Sell
36,561
-3,382
-8% -$471K 0.33% 69
2017
Q3
$5.19M Sell
39,943
-687
-2% -$91.1K 0.35% 62
2017
Q2
$5.38M Sell
40,630
-15,752
-28% -$2.01M 0.38% 59
2017
Q1
$7.02M Sell
56,382
-16,839
-23% -$2.01M 0.49% 31
2016
Q4
$8.44M Buy
73,221
+11,207
+18% +$1.29M 0.64% 24
2016
Q3
$7.33M Buy
62,014
+3,833
+7% +$465K 0.61% 24
2016
Q2
$7.06M Buy
58,181
+8,669
+18% +$985K 0.62% 25
2016
Q1
$5.36M Buy
49,512
+880
+2% +$91.1K 0.48% 35
2015
Q4
$5M Buy
48,632
+2,734
+6% +$275K 0.48% 39
2015
Q3
$4.29M Buy
45,898
+1,891
+4% +$183K 0.47% 39
2015
Q2
$4.29M Buy
44,007
+4,907
+13% +$491K 0.44% 43
2015
Q1
$3.93M Buy
39,100
+1,570
+4% +$160K 0.42% 43
2014
Q4
$3.92M Buy
37,530
+9,104
+32% +$959K 0.46% 40
2014
Q3
$3.03M Buy
28,426
+330
+1% +$34.2K 0.41% 51
2014
Q2
$2.94M Sell
28,096
-46,168
-62% -$4.67M 0.41% 54
2014
Q1
$7.29M Sell
74,264
-3,690
-5% -$342K 1.07% 10
2013
Q4
$7.14M Sell
77,954
-210
-0.3% -$19.4K 1.08% 9
2013
Q3
$6.78M Sell
78,164
-560
-0.7% -$50.2K 1.13% 9
2013
Q2
$6.76M Buy
+78,724
New +$6.68M 1.23% 9

Other funds holding JNJ

Shelton Capital Management's JNJ Position: Q1 2026 in Review

Shelton Capital Management reduced its Johnson & Johnson (JNJ) stake by 51% in Q1 2026, selling an estimated $14.9M and leaving 62,062 shares worth $15.2M. The position accounts for 0.33% of the portfolio, ranked #70.

Shelton Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.1M in Q3 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Shelton Capital Management held 62,062 shares of Johnson & Johnson worth $15.2M as of Q1 2026.
  • Shelton Capital Management sold 64,093 Johnson & Johnson shares in Q1 2026, an estimated $14.9M.
  • Johnson & Johnson made up 0.33% of Shelton Capital Management's portfolio in Q1 2026, its #70 holding.
  • Shelton Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Shelton Capital Management's Johnson & Johnson position peaked at $28.1M in Q3 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.